Adcirca and Blopress drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adcirca (tadalafil) and Blopress (candesartan cilexetil). Common drug interactions include gamma-glutamyltransferase increased among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Adcirca and Blopress. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Adcirca?

Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 54,957 Adcirca users. Check the latest studies of Adcirca.

What is Blopress?

Blopress has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 7,479 Blopress users. Check the latest studies of Blopress.



On Aug, 12, 2026

23 people who take Adcirca and Blopress together, and have interactions are studied.

Adcirca and Blopress drug interactions.

What are the common drug interactions of Adcirca and Blopress, by gender? *:

female:

  1. Gamma-glutamyltransferase increased
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Blood lactate dehydrogenase increased
  5. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  6. Hypokalaemia (low potassium)
  7. Liver disorder (liver diseases)
  8. Anaemia (lack of blood)
  9. Pyrexia (fever)
  10. Rhinitis allergic (inflammation of the nasal airways due to allergy)

male:

  1. Diarrhoea
  2. Headache (pain in head)
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Ascites (accumulation of fluid in the abdominal cavity)
  5. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  6. Infusion site erythema (reddening of the skin at infusion site)
  7. Infusion site induration
  8. Infusion site pain
  9. Weight decreased
  10. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)

What are the common drug interactions of Adcirca and Blopress, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Arthralgia (joint pain)
  2. Diarrhoea
  3. Headache (pain in head)

20-29:

n/a

30-39:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood lactate dehydrogenase increased
  4. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  5. Gamma-glutamyltransferase increased
  6. Hypokalaemia (low potassium)
  7. Liver disorder (liver diseases)
  8. Anaemia (lack of blood)
  9. Pyrexia (fever)
  10. Rhinitis allergic (inflammation of the nasal airways due to allergy)

40-49:

  1. Diarrhoea
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Pain in extremity
  6. Pain in jaw
  7. Plantar fasciitis (painful inflammatory process of the plantar fascia)
  8. Pneumonia
  9. Rash
  10. Stomatitis (inflammation of mucous membrane of mouth)

50-59:

  1. Cardiac failure
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Right ventricular failure (right half of the heart fails to work)
  5. Uterine cancer
  6. Uterine haemorrhage (uterine bleeding)
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Headache (pain in head)

60+:

  1. Diarrhoea
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Intraductal papillary mucinous neoplasm (tumour (neoplasm) that grows within the pancreatic ducts)
  4. Pancreatic enlargement
  5. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  6. Puncture site pain
  7. Skin mass
  8. White blood cell count decreased
  9. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  10. Hypoproteinaemia (too little prolactin circulating in the blood)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 20 people, 86.96%
  2. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 7 people, 30.43%
  3. Stomatitis (inflammation of mucous membrane of mouth): 5 people, 21.74%
  4. Rashes (redness): 5 people, 21.74%
  5. Nausea (feeling of having an urge to vomit): 5 people, 21.74%
  6. Nasopharyngitis (inflammation of the nasopharynx): 5 people, 21.74%
  7. Headache (pain in head): 5 people, 21.74%
  8. Muscle Aches (muscle pain): 4 people, 17.39%
  9. Gastric Ulcer (stomach ulcer): 4 people, 17.39%
  10. Diarrhea: 4 people, 17.39%

* Approximation only. Some reports may have incomplete information.

Do you take Adcirca and Blopress?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Adcirca and Blopress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adcirca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Blopress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adcirca and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Blopress and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tadalafil and candesartan cilexetil (the active ingredients of Adcirca and Blopress, respectively), and Adcirca and Blopress (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: